These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 547122)

  • 1. Effect of physostigmine and scopolamine on the memory functions of chess players.
    Liljequist R; Mattila MJ
    Med Biol; 1979; 57(6):402-5. PubMed ID: 547122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.
    Litvan I; Blesa R; Clark K; Nichelli P; Atack JR; Mouradian MM; Grafman J; Chase TN
    Ann Neurol; 1994 Jul; 36(1):55-61. PubMed ID: 8024262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic modulation of spatial working memory of mice in radial maze performance: retention curve analysis.
    Inagawa K
    Yakubutsu Seishin Kodo; 1993 Aug; 13(4):233-8. PubMed ID: 8237140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
    Ogura H; Aigner TG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):60-4. PubMed ID: 8331575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory.
    Mewaldt SP; Ghoneim MM
    Pharmacol Biochem Behav; 1979 Feb; 10(2):205-10. PubMed ID: 450929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation.
    Rasch BH; Born J; Gais S
    J Cogn Neurosci; 2006 May; 18(5):793-802. PubMed ID: 16768378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of scopolamine and physostigmine on working and reference memory in pigeons.
    Santi A; Bogles J; Petelka S
    Behav Neural Biol; 1988 Jan; 49(1):61-73. PubMed ID: 3345192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On acute effects of some drugs on the higher nervous activity in man. Scopolamine (0.6 mg), physostigmine (1.0 mg) and their interaction. Part LIII.
    Hrbek J; Macáková J; Komenda S; Siroká A; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1985; 112():185-226. PubMed ID: 2938435
    [No Abstract]   [Full Text] [Related]  

  • 10. Recall or evaluation of chess positions revisited: the relationship between memory and evaluation in chess skill.
    Schultetus RS; Charness N
    Am J Psychol; 1999; 112(4):555-69. PubMed ID: 10696266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic modulation of the hippocampus during encoding and retrieval.
    Rogers JL; Kesner RP
    Neurobiol Learn Mem; 2003 Nov; 80(3):332-42. PubMed ID: 14521875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.
    Ghoneim MM; Mewaldt SP
    Psychopharmacology (Berl); 1977 Mar; 52(1):1-6. PubMed ID: 403551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholinergic drugs on scopolamine-induced memory impairment in rhesus monkeys.
    Hironaka N; Ando K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):103-8. PubMed ID: 8905798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of scopolamine (0.6 mg), physostigmine (1.0 mg), and their complex on the blood pressure, the body temperature and the heart rate in man.
    Hrbek J; Komenda S; Macáková J; Siroká A; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1985; 112():279-94. PubMed ID: 2938438
    [No Abstract]   [Full Text] [Related]  

  • 15. Scopolamine treatment and fimbria-fornix lesions: mimetic effects on radial maze performance.
    Cassel JC; Kelche C
    Physiol Behav; 1989 Sep; 46(3):347-53. PubMed ID: 2623054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
    Matsuoka N; Maeda N; Yamazaki M; Ohkubo Y; Yamaguchi I
    J Pharmacol Exp Ther; 1992 Nov; 263(2):436-44. PubMed ID: 1432682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic challenge and cognitive functions: a comparison between young and elderly normal subjects.
    Zemishlany Z; Thorne AE
    Isr J Psychiatry Relat Sci; 1991; 28(3):32-41. PubMed ID: 1800456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of physostigmine and scopolamine on recognition memory in monkeys.
    Aigner TG; Mishkin M
    Behav Neural Biol; 1986 Jan; 45(1):81-7. PubMed ID: 3954717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neonatal lead exposure on memory in rats.
    Milar KS; Krigman MR; Grant LD
    Neurobehav Toxicol Teratol; 1981; 3(3):369-73. PubMed ID: 7290292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.